Back to search
FDAFDA · Food and drugs·Recall number Z-0425-2016

MYLA CLINIC PATCH 3.2.0 CD Product Usage: MYLA is a computer application (Middleware) based on Web 2.0 technology which: Interfaces between the instruments connected to the application and the LIS(s) (Laboratory Information System(s)).

Published December 23, 2015 · Recall initiated: November 3, 2015

Summary

FDA records medical device Class II recall Z-0425-2016, published December 23, 2015 and initiated November 3, 2015. Recalling firm: bioMerieux, Inc.; Status: Terminated; Reported quantity: 626 systems in total; Lot: REF # 414518, Serial number/Software version V3.2 CLI. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

MYLA® software connected to a Laboratory Information System (LIS) and a VITEK® 2 system has the potential to link a test result to an incorrect patient record with the same specimen ID.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
bioMerieux, Inc.
Distributor
Worldwide Distribution - US Nationwide in the states of: AK, AL, AR, AZ, CA, CT, FL, GA, HI, IA, ID, IL, IN, KS, LA, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and countries of: Foreign accounts: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, France, Germany, Greece, Hungary, India, Italy, Japan, Korea, Netherlands, Poland, Portugal, Russia, Serbia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, Angola, Puerto Rico, Republic of Belarus, Republic of Belarus, Benin, Bosnia, Brunei, Bulgaria, Burkina Faso, Cambodia, Cameroon, Chad, Democratic Republic of Congo, Costa Rica, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Ethiopia, Gabon, Guam, Guatemala, Guatemala, Guinea, Honduras, Indonesia, Iraq, Israel, Ivory Coast, Kazakhstan, Kenya, Kenya, Kuwait, Laos, Latvia, Lebanon, Libya, Lithuania, Malaysia, Malaysia, Mali, Portugal, Myanmar, Managua, Niger, Nigeria, Palestine, Philippines, Philippines, Qatar, Kingdom of Saudi Arabia, Senegal, Serbia, Slovakia, Togo, Tunisia, Ukraine, UAE, Vietnam, Vietnam, Ivory Coast and Zimbabwe.
Lot
REF # 414518, Serial number/Software version V3.2 CLI
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was MYLA CLINIC PATCH 3.2.0 CD Product Usage: MYLA is a computer application (Middleware) based on Web 2.0 technology which: Interfaces between the instruments connected to the application and the LIS(s) (Laboratory Information System(s)). recalled?

Yes. FDA published recall Z-0425-2016 on December 23, 2015. Reported hazard: MYLA® software connected to a Laboratory Information System (LIS) and a VITEK® 2 system has the potential to link a test result to an incorrect patient record with the same specimen ID.

What should I do if I have this product?

Voluntary: Firm initiated · Letter